273 related articles for article (PubMed ID: 2085427)
1. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
Bigazzi R; Atti M; Baldari G
Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin.
Pegues DA; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Gordon SM; Favero MS; Jarvis WR
J Am Soc Nephrol; 1992 Oct; 3(4):1002-7. PubMed ID: 1450362
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
[No Abstract] [Full Text] [Related]
4. [Role of tumor necrosis factor in hemodiafiltration].
Tetta C; Segoloni G; Fidelio T; Licata C; Sancipriano GP; Iacono G; Ragni R; Vercellone A
Minerva Urol Nefrol; 1991; 43(3):181-3. PubMed ID: 1817342
[TBL] [Abstract][Full Text] [Related]
5. [Hypersensitivity reactions during hemodialysis. Role of high permeability, retrofiltration and bacterial contamination of the dialysate].
Montagnac R; Schillinger F; Milcent T; Croix JC
Nephrologie; 1988; 9(1):29-32. PubMed ID: 3134622
[TBL] [Abstract][Full Text] [Related]
6. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.
Lonnemann G; Sereni L; Lemke HD; Tetta C
Artif Organs; 2001 Dec; 25(12):951-60. PubMed ID: 11843762
[TBL] [Abstract][Full Text] [Related]
7. Potential transfer of endotoxin across high-flux polysulfone membranes.
Bommer J; Becker KP; Urbaschek R
J Am Soc Nephrol; 1996 Jun; 7(6):883-8. PubMed ID: 8793797
[TBL] [Abstract][Full Text] [Related]
8. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes.
Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
Contrib Nephrol; 1989; 74():58-65. PubMed ID: 2702147
[No Abstract] [Full Text] [Related]
9. Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood.
Linnenweber S; Lonnemann G
ASAIO J; 2000; 46(4):444-7. PubMed ID: 10926143
[TBL] [Abstract][Full Text] [Related]
10. Filtration of dialysate using an on-line dialysate filter.
Frinak S; Polaschegg HD; Levin NW; Pohlod DJ; Dumler F; Saravolatz LD
Int J Artif Organs; 1991 Nov; 14(11):691-7. PubMed ID: 1757155
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Hypersensitivity Reactions During Hemodialysis.
Esteras R; Martín-Navarro J; Ledesma G; Fernández-Prado R; Carreño G; Cintra M; Cidraque I; Sanz I; Tarragón B; Alexandru S; Milla M; Astudillo E; Sánchez E; Mas S; Tejeiro RD; Ortiz A; Sánchez R; González-Parra E
Kidney Blood Press Res; 2018; 43(5):1472-1478. PubMed ID: 30235456
[TBL] [Abstract][Full Text] [Related]
12. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS).
Laude-Sharp M; Caroff M; Simard L; Pusineri C; Kazatchkine MD; Haeffner-Cavaillon N
Kidney Int; 1990 Dec; 38(6):1089-94. PubMed ID: 2127434
[TBL] [Abstract][Full Text] [Related]
13. The effects of endotoxin-contaminated dialysate and polysulfone or cellulosic membranes on the release of TNF alpha during simulated dialysis.
Arduino MJ; Bland LA; McAllister SK; Favero MS
Artif Organs; 1995 Sep; 19(9):880-6. PubMed ID: 8687293
[TBL] [Abstract][Full Text] [Related]
14. The past, present and future of the dialyzer.
Mineshima M
Contrib Nephrol; 2015; 185():8-14. PubMed ID: 26023010
[TBL] [Abstract][Full Text] [Related]
15. Ultrafiltration and endotoxin removal from dialysis fluids.
Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. I. Radiolabeled endotoxin.
Ureña P; Herbelin A; Basile C; Zingraff J; Man NK; Drüeke T
Contrib Nephrol; 1989; 74():71-8. PubMed ID: 2702149
[No Abstract] [Full Text] [Related]
17. Membranes for endotoxin removal from dialysate: considerations on feasibility of commercial ceramic membranes.
Bender H; Pfläzel A; Saunders N; Czermak P; Catapano G; Vienken J
Artif Organs; 2000 Oct; 24(10):826-9. PubMed ID: 11091173
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
19. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin.
Gordon SM; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Favero MS; Jarvis WR
J Am Soc Nephrol; 1992 Mar; 2(9):1436-44. PubMed ID: 1627766
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the DialGuard device for endotoxin removal in hemodialysis.
Szathmary S; Hegyi E; Amoureux MC; Rajapakse N; Chicorka L; Szalai G; Reszegi K; Derbyshire Z; Paluh J; Dodson B; Grandics P
Blood Purif; 2004; 22(5):409-15. PubMed ID: 15316195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
